×




The Brave New World of Valuing Life Sciences and Healthcare Enterprises Net Present Value (NPV) / MBA Resources

Introduction to Net Present Value (NPV) - What is Net Present Value (NPV) ? How it impacts financial decisions regarding project management?

NPV solution for The Brave New World of Valuing Life Sciences and Healthcare Enterprises case study


At Oak Spring University, we provide corporate level professional Net Present Value (NPV) case study solution. The Brave New World of Valuing Life Sciences and Healthcare Enterprises case study is a Harvard Business School (HBR) case study written by Carol W. Carden, Travis Chamberlain, John W. Hill. The The Brave New World of Valuing Life Sciences and Healthcare Enterprises (referred as “Healthcare Sciences” from here on) case study provides evaluation & decision scenario in field of Technology & Operations. It also touches upon business topics such as - Value proposition, .

The net present value (NPV) of an investment proposal is the present value of the proposal’s net cash flows less the proposal’s initial cash outflow. If a project’s NPV is greater than or equal to zero, the project should be accepted.

NPV = Present Value of Future Cash Flows LESS Project’s Initial Investment






Case Description of The Brave New World of Valuing Life Sciences and Healthcare Enterprises Case Study


Life sciences and healthcare enterprises represent the largest industry in the U.S. economy. Given the importance of this sector, there is increasing demand for financial valuation of both publicly and privately held companies. At the same time, accurate valuation is particularly difficult in light of shifting business models, the current economy, intellectual property rights issues, continuous innovation in the sector, changing population demographics, quality issues, and government involvement in healthcare debate, discussion, and regulation. Herein, we examine the changing and increasingly problematic valuation of life sciences and healthcare enterprises that have obvious importance from a social welfare perspective.


Case Authors : Carol W. Carden, Travis Chamberlain, John W. Hill

Topic : Technology & Operations

Related Areas :




Calculating Net Present Value (NPV) at 6% for The Brave New World of Valuing Life Sciences and Healthcare Enterprises Case Study


Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 6 %
Discounted
Cash Flows
Year 0 (10027058) -10027058 - -
Year 1 3471216 -6555842 3471216 0.9434 3274732
Year 2 3970982 -2584860 7442198 0.89 3534160
Year 3 3957600 1372740 11399798 0.8396 3322877
Year 4 3235646 4608386 14635444 0.7921 2562935
TOTAL 14635444 12694704




The Net Present Value at 6% discount rate is 2667646

In isolation the NPV number doesn't mean much but put in right context then it is one of the best method to evaluate project returns. In this article we will cover -

Different methods of capital budgeting


What is NPV & Formula of NPV,
How it is calculated,
How to use NPV number for project evaluation, and
Scenario Planning given risks and management priorities.




Capital Budgeting Approaches

Methods of Capital Budgeting


There are four types of capital budgeting techniques that are widely used in the corporate world –

1. Internal Rate of Return
2. Net Present Value
3. Profitability Index
4. Payback Period

Apart from the Payback period method which is an additive method, rest of the methods are based on Discounted Cash Flow technique. Even though cash flow can be calculated based on the nature of the project, for the simplicity of the article we are assuming that all the expected cash flows are realized at the end of the year.

Discounted Cash Flow approaches provide a more objective basis for evaluating and selecting investment projects. They take into consideration both –

1. Magnitude of both incoming and outgoing cash flows – Projects can be capital intensive, time intensive, or both. Healthcare Sciences shareholders have preference for diversified projects investment rather than prospective high income from a single capital intensive project.
2. Timing of the expected cash flows – stockholders of Healthcare Sciences have higher preference for cash returns over 4-5 years rather than 10-15 years given the nature of the volatility in the industry.






Formula and Steps to Calculate Net Present Value (NPV) of The Brave New World of Valuing Life Sciences and Healthcare Enterprises

NPV = Net Cash In Flowt1 / (1+r)t1 + Net Cash In Flowt2 / (1+r)t2 + … Net Cash In Flowtn / (1+r)tn
Less Net Cash Out Flowt0 / (1+r)t0

Where t = time period, in this case year 1, year 2 and so on.
r = discount rate or return that could be earned using other safe proposition such as fixed deposit or treasury bond rate. Net Cash In Flow – What the firm will get each year.
Net Cash Out Flow – What the firm needs to invest initially in the project.

Step 1 – Understand the nature of the project and calculate cash flow for each year.
Step 2 – Discount those cash flow based on the discount rate.
Step 3 – Add all the discounted cash flow.
Step 4 – Selection of the project

Why Technology & Operations Managers need to know Financial Tools such as Net Present Value (NPV)?

In our daily workplace we often come across people and colleagues who are just focused on their core competency and targets they have to deliver. For example marketing managers at Healthcare Sciences often design programs whose objective is to drive brand awareness and customer reach. But how that 30 point increase in brand awareness or 10 point increase in customer touch points will result into shareholders’ value is not specified.

To overcome such scenarios managers at Healthcare Sciences needs to not only know the financial aspect of project management but also needs to have tools to integrate them into part of the project development and monitoring plan.

Calculating Net Present Value (NPV) at 15%

After working through various assumptions we reached a conclusion that risk is far higher than 6%. In a reasonably stable industry with weak competition - 15% discount rate can be a good benchmark.



Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 15 %
Discounted
Cash Flows
Year 0 (10027058) -10027058 - -
Year 1 3471216 -6555842 3471216 0.8696 3018449
Year 2 3970982 -2584860 7442198 0.7561 3002633
Year 3 3957600 1372740 11399798 0.6575 2602186
Year 4 3235646 4608386 14635444 0.5718 1849991
TOTAL 10473259


The Net NPV after 4 years is 446201

(10473259 - 10027058 )








Calculating Net Present Value (NPV) at 20%


If the risk component is high in the industry then we should go for a higher hurdle rate / discount rate of 20%.

Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 20 %
Discounted
Cash Flows
Year 0 (10027058) -10027058 - -
Year 1 3471216 -6555842 3471216 0.8333 2892680
Year 2 3970982 -2584860 7442198 0.6944 2757626
Year 3 3957600 1372740 11399798 0.5787 2290278
Year 4 3235646 4608386 14635444 0.4823 1560400
TOTAL 9500984


The Net NPV after 4 years is -526074

At 20% discount rate the NPV is negative (9500984 - 10027058 ) so ideally we can't select the project if macro and micro factors don't allow financial managers of Healthcare Sciences to discount cash flow at lower discount rates such as 15%.





Acceptance Criteria of a Project based on NPV

Simplest Approach – If the investment project of Healthcare Sciences has a NPV value higher than Zero then finance managers at Healthcare Sciences can ACCEPT the project, otherwise they can reject the project. This means that project will deliver higher returns over the period of time than any alternate investment strategy.

In theory if the required rate of return or discount rate is chosen correctly by finance managers at Healthcare Sciences, then the stock price of the Healthcare Sciences should change by same amount of the NPV. In real world we know that share price also reflects various other factors that can be related to both macro and micro environment.

In the same vein – accepting the project with zero NPV should result in stagnant share price. Finance managers use discount rates as a measure of risk components in the project execution process.

Sensitivity Analysis

Project selection is often a far more complex decision than just choosing it based on the NPV number. Finance managers at Healthcare Sciences should conduct a sensitivity analysis to better understand not only the inherent risk of the projects but also how those risks can be either factored in or mitigated during the project execution. Sensitivity analysis helps in –

What are the uncertainties surrounding the project Initial Cash Outlay (ICO’s). ICO’s often have several different components such as land, machinery, building, and other equipment.

What are the key aspects of the projects that need to be monitored, refined, and retuned for continuous delivery of projected cash flows.

What will be a multi year spillover effect of various taxation regulations.

What can impact the cash flow of the project.

Understanding of risks involved in the project.

Some of the assumptions while using the Discounted Cash Flow Methods –

Projects are assumed to be Mutually Exclusive – This is seldom the came in modern day giant organizations where projects are often inter-related and rejecting a project solely based on NPV can result in sunk cost from a related project.

Independent projects have independent cash flows – As explained in the marketing project – though the project may look independent but in reality it is not as the brand awareness project can be closely associated with the spending on sales promotions and product specific advertising.






Negotiation Strategy of The Brave New World of Valuing Life Sciences and Healthcare Enterprises

References & Further Readings

Carol W. Carden, Travis Chamberlain, John W. Hill (2018), "The Brave New World of Valuing Life Sciences and Healthcare Enterprises Harvard Business Review Case Study. Published by HBR Publications.


PS Group Holdings Ltd SWOT Analysis / TOWS Matrix

Basic Materials , Misc. Fabricated Products


600 Group SWOT Analysis / TOWS Matrix

Capital Goods , Misc. Capital Goods


Coway SWOT Analysis / TOWS Matrix

Services , Rental & Leasing


Rimbunan Sawit SWOT Analysis / TOWS Matrix

Consumer/Non-Cyclical , Crops


Powdertech SWOT Analysis / TOWS Matrix

Consumer Cyclical , Photography


Hengkang Medical A SWOT Analysis / TOWS Matrix

Healthcare , Biotechnology & Drugs


Fauvet Girel SWOT Analysis / TOWS Matrix

Financial , Investment Services


Madison Holdings SWOT Analysis / TOWS Matrix

Consumer/Non-Cyclical , Beverages (Alcoholic)